Reports

Price increases disproportionately harm Black and Latino patients

Big Pharma's influence on patient advocacy groups

The BURDEN of Cancer Drug Prices On Patients. The RELIEF in the Inflation Reduction Act.

In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients

Methodology and Dataset for July 2022 Price Hikes Report

This report examines the practices of BMS/Pfizer and Johnson & Johnson's lockstep price hikes and patent gaming on two blockbuster blood thinners and the implications for patients and taxpayers.

Drug companies raised the prices of 742 drugs in January 2022

Methodology and Dataset for January Price Hikes 2.0 Report